Key Points
- CEO Kevin Mcnamara sold 2,000 shares on March 12 at an average price of $403.18 for proceeds of $806,360, reducing his direct stake to 93,719 shares (a 2.09% decrease), according to an SEC filing.
- Chemed missed quarterly estimates, reporting EPS of $6.42 vs. $7.02 expected and revenue of $639.34M vs. $659.09M, but set FY2026 guidance of $23.25–$24.25 EPS—above analysts' current consensus of about 21.43.
- The firm declared a $0.60 quarterly dividend ($2.40 annualized, 0.6% yield) and faces mixed analyst sentiment with a consensus "Hold" rating and an average price target of $498 after several downgrades.
Chemed Corporation (NYSE:CHE - Get Free Report) CEO Kevin Mcnamara sold 2,000 shares of the company's stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total value of $806,360.00. Following the transaction, the chief executive officer directly owned 93,719 shares in the company, valued at $37,785,626.42. This represents a 2.09% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Chemed Stock Performance
Shares of CHE opened at $402.03 on Friday. The business has a 50-day moving average of $441.48 and a 200 day moving average of $440.96. Chemed Corporation has a fifty-two week low of $385.00 and a fifty-two week high of $623.60. The firm has a market cap of $5.54 billion, a P/E ratio of 21.89, a price-to-earnings-growth ratio of 1.58 and a beta of 0.46.
Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.02 by ($0.60). The firm had revenue of $639.34 million during the quarter, compared to the consensus estimate of $659.09 million. Chemed had a net margin of 10.48% and a return on equity of 25.66%. The company's revenue was down .1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.83 earnings per share. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, research analysts predict that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.
Chemed Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Monday, February 23rd were given a $0.60 dividend. The ex-dividend date of this dividend was Monday, February 23rd. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. Chemed's payout ratio is 13.06%.
Analysts Set New Price Targets
CHE has been the subject of several analyst reports. Jefferies Financial Group downgraded shares of Chemed from a "buy" rating to a "hold" rating in a report on Thursday, January 22nd. Royal Bank Of Canada reissued a "sector perform" rating and set a $422.00 target price (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Weiss Ratings restated a "hold (c-)" rating on shares of Chemed in a research report on Wednesday, January 21st. Oppenheimer reduced their price target on Chemed from $580.00 to $500.00 and set an "outperform" rating for the company in a research report on Friday, February 27th. Finally, Zacks Research lowered Chemed from a "hold" rating to a "strong sell" rating in a research note on Wednesday, March 4th. Two analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $498.00.
Check Out Our Latest Analysis on CHE
Hedge Funds Weigh In On Chemed
Several hedge funds have recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd increased its holdings in Chemed by 50.3% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 245 shares of the company's stock worth $105,000 after acquiring an additional 82 shares during the period. Monetary Solutions Ltd purchased a new stake in Chemed in the 4th quarter worth approximately $25,000. Alberta Investment Management Corp bought a new position in Chemed in the 4th quarter valued at $1,241,000. Mercer Global Advisors Inc. ADV grew its position in shares of Chemed by 29.7% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 2,939 shares of the company's stock valued at $1,258,000 after purchasing an additional 673 shares in the last quarter. Finally, EP Wealth Advisors LLC purchased a new position in shares of Chemed during the 4th quarter valued at $451,000. Hedge funds and other institutional investors own 95.85% of the company's stock.
Chemed Company Profile
(
Get Free Report)
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
